Gainers
- DBV Technologies (NASDAQ:DBVT) shares moved upwards by 38.6% to $2.12 during Tuesday's after-market session. This security traded at a volume of 406.9K shares come close, making up 171.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $233.6 million.
- Eloxx Pharmaceuticals (NASDAQ:ELOX) shares moved upwards by 14.34% to $0.35. The market value of their outstanding shares is at $30.2 million.
- Scholar Rock Holding (NASDAQ:SRRK) stock moved upwards by 12.58% to $6.98. The company's market cap stands at $246.4 million.
- AcelRx Pharmaceuticals (NASDAQ:ACRX) shares increased by 11.45% to $0.24. This security traded at a volume of 53.5K shares come close, making up 4.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $34.9 million.
- Exscientia (NASDAQ:EXAI) shares increased by 10.9% to $14.85. The market value of their outstanding shares is at $1.8 billion.
- Precigen (NASDAQ:PGEN) shares increased by 10.45% to $1.69. The market value of their outstanding shares is at $351.0 million.
Losers
- Butterfly Network (NYSE:BFLY) stock decreased by 8.2% to $3.27 during Tuesday's after-market session. The company's market cap stands at $650.5 million.
- Spero Therapeutics (NASDAQ:SPRO) shares declined by 8.01% to $1.15. The market value of their outstanding shares is at $37.7 million.
- Citius Pharmaceuticals (NASDAQ:CTXR) stock fell 7.77% to $0.95. The company's market cap stands at $138.8 million.
- Biocept (NASDAQ:BIOC) stock fell 7.65% to $1.45. The company's market cap stands at $24.5 million.
- Liquidia (NASDAQ:LQDA) stock declined by 7.61% to $4.13. The company's market cap stands at $265.7 million.
- Alaunos Therapeutics (NASDAQ:TCRT) stock fell 7.47% to $0.63. Alaunos Therapeutics's trading volume hit 208.2K shares by close, accounting for 7.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $136.0 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.